Press release
Global Congestive Heart Failure Drugs Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028
The congestive heart failure drugs market is anticipated to grow at a significant CAGR of 16.1% during the forecast period (2022-2028). Some of the congestive heart failure drugs such as angiotensin-converting enzyme inhibitors are given in a state of congestive heart failure. This works by relaxing the blood vessels of the heart. Some angiotensin-converting enzyme inhibitors are ramipril, enalapril, and lisinopril. Angiotensin-2 receptor blockers are also used to relax blood vessels of the heart and some of them are valsartan and candesartan. An increase in the number of heart failure patients is the major factor that has surged the demand for such drugs and the heart failure prevalence is expected to drive the market during the forecast period. For instance, in June 2020,as per an article published in the AME Medical Journal, there were around 64.34 million cases of Heart Failure in the world.A full report of Global Congestive Heart Failure Drugs Market is available at:https://orionmarketreports.com/global-congestive-heart-failure-drugs-market/109560/
Some major players operating in the congestive heart failure drugs market include Amgen Inc, Glaxo SmithKline Plc, Pfizer Inc, Teva Pharmaceutical Industries Ltd. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in May 2020, Food and Drug Administration has approved the Farxiga drug which is useful in the treatment of congestive heart failure. This drug is manufactured by AstraZeneca Pharmaceuticals LP. This drug has been found effective in reducing the ejection fraction and decreasing the risk of hospitalization and death in case of heart failure. This drug belongs to a class of sodium-glucose co-transporter 2 inhibitors.
Market Coverage
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Drug Type
By End-User
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape-Amgen Inc, Glaxo Smith Kline Plc, Pfizer Inc, Teva Pharmaceutical Industries Ltd.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Congestive Heart Failure Drugs MarketReport by Segment
By Drug Type
ACE Inhibitors
Angiotensin 2 Receptor Blockers
Beta Blockers
Mineral corticoid Receptor Antagonists
Diuretics
Ivabradine
Sacubritil Valsartan
Hydralazine With Nitrate
Digoxin
By End-User
Hospital
Clinic
Others
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Congestive Heart Failure Drugs Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028 here
News-ID: 2635925 • Views: …
More Releases from Orion Market Reports
Sodium Cromoglicate API Market to Expand With Strong Development by 2031
The Sodium Cromoglicate API Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Sodium Cromoglicate API (active pharmaceutical ingredient) is a type of medication used to treat allergic conditions such as hay fever, allergic conjunctivitis, and asthma. It works by stabilizing mast cells and preventing the release of allergic substances that cause symptoms like itching, redness, and swelling.
Sodium Cromoglicate API Market…
Soda Ash and Aluminium Trihydrate (ATH) Market Will Generate Record Revenue by 2 …
The Soda Ash and Aluminium Trihydrate (ATH) Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). Soda Ash, also known as sodium carbonate, is a white, odorless powder used in manufacturing glass, detergents, chemicals, and other industrial applications. Aluminium Trihydrate (ATH) is a white, non-toxic powder primarily used as a flame retardant in plastics, rubber, and textiles.
Soda Ash and Aluminium Trihydrate…
Single Crystal Silicon Wafers Market Provides Information on Historical Growth, …
The Single Crystal Silicon Wafers Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). Single crystal silicon wafers are thin, disc-shaped substrates made from a single crystal of silicon. They are a fundamental component in the semiconductor industry and serve as the foundation for manufacturing integrated circuits (ICs) and other microelectronic devices.
Single Crystal Silicon Wafers Market research analyzes the entire market,…
Silicone For Personal Care Market Growth Drivers, Developments, Technology And F …
The Silicone For Personal Care Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Silicone for personal care refers to the use of silicone-based ingredients and formulations in various cosmetic and personal care products. Silicone compounds are valued in the personal care industry for their unique properties, including their smooth texture, excellent spreadability, water resistance, film-forming ability, and compatibility with skin…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
